Swvl Holdings (NASDAQ:SWVL) announced its financial results for the three months ended March 31, 2026, revealing a substantial 68% year-over-year increase in total revenue to $8.2M.
Ethereum climbed 8.46 percent over the past 24 hours to reach $1,805.94, outperforming the broader cryptocurrency market, which advanced 7.69 percent during the same period.
Clinical-stage biotech company Clearmind Medicine (NASDAQ:CMND) has successfully completed the dosing of all 24 healthy participants in Part A of its FDA-regulated Phase I/II trial evaluating its proprietary compound, CMND-100, for the treatment of Alcohol Use Disorder.
Solana Company (NASDAQ:HSDT) rejected an unsolicited all-stock acquisition proposal from Forward Industries (NASDAQ:FWDI) valuing the business at $1.48 per share.
Clinical-stage biopharmaceutical firm HCW Biologics (NASDAQ:HCWB) reported positive preliminary human data from its Phase 1 trial of HCW9302, revealing that all three mild alopecia areata patients in the 3 μg/kg cohort achieved a 25% or greater reduction in SALT scores.
NovaBridge Biosciences (NASDAQ:NBP) received FDA Fast Track Designation for its bispecific antibody givastomig to treat advanced gastric adenocarcinoma expressing Claudin 18.2 protein levels.
Trinity Biotech (NASDAQ:TRIB) secured new purchase orders for over 2 million HIV tests to support its annual financial objectives.
Zai Lab (NASDAQ:ZLAB) has received European orphan drug designation for its antibody-drug conjugate targeting 375,000 annual lung cancer cases.
Nebius (NASDAQ:NBIS) completed its corporate acquisition of model optimization developer Eigen AI on June 10, 2026.
Vince Holding (NASDAQ:VNCE) reported a 10.5% increase in first-quarter net sales to $64 million, driven by expansion across its direct-to-consumer and wholesale segments.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
-640x360.webp&w=3840&q=75)
